View Author
scopus: 8083141300

Webster, M.W.I.

(Mark Webster)


stent restenosi patient study follow-up month angiographic analysis ⅐⅐⅐ vessel lesion 6 months diameter coll cardiol ultrasound implantation balloon angioplasty result angioplasty 6- month follow-up absorption echogenicity diabetes benestent 2- year follow-up trial intervention reference serruy plaque predictor absorption process cardiol artery multivariate analysis table stented circulation diabetic tissue process angiography in-stent restenosis bioabsorbable percutaneou value reference diameter angiographic results vessel caliber stenting stenosi disease balloon change factor variable stent deployment angiographic follow-up diabetes mellitus length angina in-stent multivariate nondiabetic lesion severity symptom screening method stented length procedure outcome univariate heart artery disease image eur heart j van der giessen hyperechogenicity regression 6- month




3 Most Recent Publications

Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters: A feasibility study (Article)
Bruining, N. Winter, S. de Thuesen, L. Ormiston, J.A. Cheong, W.F. Miquel-Hébert, K. Veldhof, S. Serruys, P.W.J.C. Roelandt, J.R.T.C. Regar, E.S. Heller, I. Domburg, R.T. van Hamers, R. Onuma, Y. Dudek, D. Webster, M.W.I.
2010-03-01
Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. (Article)
West, N.E. Ruygrok, P.N. Disco, C. Webster, M.W.I. Lindeboom, W.K. O'Neill, W.W. Mercado, N.F. Serruys, P.W.J.C.
2004-02-24
Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention (Article)
Ruygrok, P.N. Webster, M.W.I. Valk, V. de Es, G.A. van Ormiston, J.A. Morel, M-A.M. Serruys, P.W.J.C.
2001-01-01